Karuna Therapeutics to Present at the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Karuna Therapeutics, Inc. (NASDAQ: KRTX) will present at the SVB Securities Global Biopharma Conference on February 14, 2023, at 2:20 p.m. EST. The conference will showcase Karuna's commitment to developing transformative medicines for psychiatric and neurological conditions. A live webcast of the presentation will be available on the Investor Relations page of Karuna's website, and a replay will be archived for up to 30 days post-conference. Karuna focuses on creating differentiated treatments that address critical patient needs by utilizing advanced neuroscience insights.

BOSTON--(BUSINESS WIRE)-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 2:20 p.m. EST.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005220/en/

Investors:

Alexis Smith

518-338-8990

asmith@karunatx.com

Media:

Bob Josefsberg

646-734-3584

bjosefsberg@karunatx.com

Source: Karuna

FAQ

When is Karuna Therapeutics presenting at the SVB Securities Global Biopharma Conference?

Karuna Therapeutics will present at the SVB Securities Global Biopharma Conference on February 14, 2023, at 2:20 p.m. EST.

Where can I watch the Karuna Therapeutics conference presentation?

You can watch the Karuna Therapeutics conference presentation live on the Investor Relations page of their website.

Is there a replay available for the Karuna Therapeutics conference presentation?

Yes, a replay of the Karuna Therapeutics conference presentation will be available for up to 30 days on their website.

What is the focus of Karuna Therapeutics?

Karuna Therapeutics is focused on developing transformative medicines for people with psychiatric and neurological conditions.